The DOI matches its Crossref record.
Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors
Abstract
A series of 43 adrenocortical tumors was analyzed using nine histologic features. Mitotic activity, especially with atypical forms, and venous invasion correlated best with metastasizing or recurring tumors; however, no single criterion was useful alone. The combination of the following nine criteria was most useful in distinguishing malignant from benign tumors: nuclear grade III or IV; mitotic rate greater than 5/50 high-power fields; atypical mitoses; clear cells comprising 25% or less of the tumor; a diffuse architecture; microscopic necrosis; and invasion of venous, sinusoidal, and capsular structures. None of the 24 tumors with two or less of these criteria metastasized or recurred, while all but one of the 19 tumors with four or more of these criteria either recurred or metastasized.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the initial study by Weiss, the features with the strongest association to outcome were the mitotic rate >5/50 high powered field, atypical mitoses, and venous invasion (111) and in the second study by Weiss in 1989 the strongest association with patient outcome was the mitotic rate (112).”
From Adrenal incidentaloma (2020) · cites this paper as [111]
In the citing paper
“The most widely used histological scoring system is the Weiss score (Table 4) based on 9 histological parameters (scored as 0 if absent and 1 if present) (110,111).”
From Adrenal incidentaloma (2020) · cites this paper as [111]
Citations
Cited by
Sorted by citations
Items 101–200 of 921
Indicators of Malignancy of Canine Adrenocortical Tumors: Histopathology and Proliferation Index
Labelle, P., Kyles, A. E., Farver, T. B., et al. (2004) · Veterinary Pathology · doi:10.1354/vp.41-5-490 · Cited by 78
Nakamura, Y., Satoh, F., Morimoto, R., Kudo, M., Takase, K., Gómez-Sánchez, C. E., Honma, S., Okuyama, M., Yamashita, K., Rainey, W. E., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2785 · Cited by 78
Cytotoxic treatment of adrenocortical carcinoma
Ahlman, H., Khorram‐Manesh, A., Jansson, S. K. G., Wängberg, B., Nilsson, O., Jacobsson, C., & Lindstedt, S. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0031-6 · Cited by 78
Gaffey, M. J., Traweek, S. T., Mills, S. E., Travis, W. D., Lack, E. E., Medeiros, L. J., & Weiss, L. M. (1992) · Human Pathology · doi:10.1016/0046-8177(92)90235-u · Cited by 77
Self-citationAdrenocortical carcinoma. An immunohistochemical comparison with renal cell carcinoma.
Wick, M. R., Cherwitz, D. L., McGlennen, R. C., et al. (1986) · PubMed · Cited by 77
Laparoscopic adrenalectomy for malignant disease
Saunders, B., & Doherty, G. M. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01647-x · Cited by 74
Pathological and molecular features of adrenocortical carcinoma: an update
Volante, M., Buttigliero, C., Greco, E., Berruti, A., & Papotti, M. G. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.050625 · Cited by 74
Adrenaloma: A Call for More Aggressive Management
Linos, D. A., Stylopoulos, N., & Raptis, S. (1996) · World Journal of Surgery · doi:10.1007/s002689900120 · Cited by 72
Childhood adrenocortical tumors: Case series and reevaluation of prognosis—A 24-year experience
Mayer, S., Oligny, L. L., Deal, C., et al. (1997) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(97)90649-7 · Cited by 72
Demeure, M. J., Coan, K. E., Grant, C. S., KOMOROWSKI, R. A., Stephan, E., Sinari, S. A., Mount, D. W., & Bussey, K. J. (2013) · Surgery · doi:10.1016/j.surg.2013.06.058 · Cited by 73
Myxoid Neoplasms of the Adrenal Cortex
Brown, F. M., Gaffey, T. A., Wold, L. E., & Lloyd, R. V. (2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200003000-00008 · Cited by 71
Moulton, J. S., & Moulton, J. S. (1988) · Seminars in Roentgenology · doi:10.1016/s0037-198x(88)80039-7 · Cited by 73
Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma
Sasano, H., Suzuki, T., & Moriya, T. (2006) · Endocrine Pathology · doi:10.1007/s12022-006-0006-0 · Cited by 69
Oncocytic Adrenocortical Tumors
Duregon, E., Volante, M., Cappia, S., Cuccurullo, A., Bisceglia, M., Wong, D., Spagnolo, D. V., Szpak‐Ulczok, S., Bollito, E., Daffara, F., et al. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31822da401 · Cited by 70
DNA methylation is an independent prognostic marker of survival in adrenocortical cancer
Jouinot, A., Assié, G., Libé, R., Faßnacht, M., Papathomas, T. G., Barreau, O., Villéon, B. D. L., Faillot, S., Hamzaoui, N., Néou, M., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3205 · Cited by 71
Challenges in surgical pathology of adrenocortical tumours
Erickson, L. A. (2018) · Histopathology · doi:10.1111/his.13255 · Cited by 70
Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm
Arola, J. T., Liu, J., Heikkilä, P., Ilvesmäki, V., Salmenkivi, K., Voutilainen, R., & Kahri, A. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1650223 · Cited by 70
Treatment of Adrenocortical Carcinoma
Vaidya, A., Nehs, M. A., & Kilbridge, K. L. (2019) · Surgical pathology clinics · doi:10.1016/j.path.2019.08.010 · Cited by 71
FDG PET in the Management of Patients with Adrenal Masses and Adrenocortical Carcinoma
Deandreis, D., Leboulleux, S., Caramella, C., Schlumberger, M. J., & Baudin, É. (2011) · Hormones and Cancer · doi:10.1007/s12672-011-0091-5 · Cited by 69
Andrenocortical Carcinomas: Twelve‐year Prospective Experience
Tauchmanovà, L., Colao, A., Marzano, L. A., Sparano, L., Camera, L., Rossi, A., Palmieri, G., Marzano, E., Salvatore, M., Pettinato, G., et al. (2004) · World Journal of Surgery · doi:10.1007/s00268-004-7296-5 · Cited by 69
Angiogenesis in Human Normal and Pathologic Adrenal Cortex
BERNINI, G. P., Moretti, A., Bonadio, A. G., Menicagli, M., Viacava, P., Naccarato, A. G., Iacconi, P., Miccoli, P., & Salvetti, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011799 · Cited by 69
Update on tumours of the adrenal cortex, phaeochromocytoma and extra‐adrenal paraganglioma
McNicol, A. M. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03613.x · Cited by 68
Kitamoto, T., Suematsu, S., Yamazaki, Y., Nakamura, Y., Sasano, H., Matsuzawa, Y., Saito, J., Omura, M., & Nishikawa, T. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3284 · Cited by 70
Reincke, M., Beuschlein, F., Latrônico, A. C., Arlt, W., Chrousos, G. P., & Allolio, B. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.1991009.x · Cited by 68
Picard, C., Orbach, D. H., Carton, M., Brugières, L., Renaudin, K., Aubert, S., Berrebi, D. D., Galmiche, L., Dujardin, F., Leblond, P., et al. (2018) · Modern Pathology · doi:10.1038/s41379-018-0174-8 · Cited by 67
de Fraipont, F., Atifi, M. E., Gicquel, C., BERTAGNA, X. Y., CHAMBAZ, E. M., & Feige, J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7012 · Cited by 67
Graham, D. J., & McHenry, C. R. (1998) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30243-6 · Cited by 66
Baudin, É. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.03.001 · Cited by 66
Hazards of laparoscopic adrenalectomy for Conn's adenoma
Foxius, A., Ramboux, A., Lefebvre, Y., et al. (1999) · Surgical Endoscopy · doi:10.1007/s004649901080 · Cited by 66
Immunocytochemistry in adrenocortical tumours: A clinicomorphological study of 72 neoplasms
Schröder, S., Padberg, B.-C., Achilles, E. G., Holl, K., Dralle, H., & Klöppel, G. (1992) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01605986 · Cited by 66
Adrenocortical Carcinoma: Surgery and Mitotane for Treatment and Steroid Profiles for Follow‐up
Khorram‐Manesh, A., Ahlman, H., Jansson, S., Wängberg, B., Nilsson, O., Jakobsson, C. E., Eliasson, B., Lindstedt, S., & Tisell, L. E. (1998) · World Journal of Surgery · doi:10.1007/s002689900442 · Cited by 65
Kiseljak-Vassiliades, K., Bancos, I., Hamrahian, A., Habra, M. A., Vaidya, A., Levine, A. C., & Else, T. (2020) · Endocrine Practice · doi:10.4158/dscr-2020-0567 · Cited by 66
“The diagnosis can generally be made using routine hematoxylin and eosin staining, from which the Weiss score can be derived (Table 3), providing the final diagnosis of an ACC (Weiss score >3) (23,24).”
MethodConservative and surgical management of incidentally discovered adrenal tumors (incidentalomas)
Jockenhövel, F., Kuck, W., Hauffa, B. P., Reinhardt, W., Benker, G., Lederbogen, S., Olbricht, T., & REINWEIN, D. (1992) · Journal of Endocrinological Investigation · doi:10.1007/bf03348745 · Cited by 61
Sasano, H., SUZUKI, T. A., Nagura, H., & Nishikawa, T. (1993) · Human Pathology · doi:10.1016/0046-8177(93)90088-x · Cited by 63
Lam, A. K.-Y. (2021) · Biomedicines · doi:10.3390/biomedicines9020175 · Cited by 62
A Case Report in Favor of a Multistep Adrenocortical Tumorigenesis
Bernard, M., Sidhu, S. B., Berger, N., Peix, J., Marsh, D. J., Robinson, B. G., Gaston, V., Bouc, Y. L., & Gicquel, C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021117 · Cited by 62
Ozimek, A., Diebold, J., Linke, R., Heyn, J., Hallfeldt, K. K. J., & Mussack, T. (2008) · Endocrine Journal · doi:10.1507/endocrj.k08e-035 · Cited by 63
Adrenocortical carcinoma: a practical guide for clinicians
Faßnacht, M., Puglisi, S., Kimpel, O., & Terzolo, M. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00378-4 · Cited by 66
Cazejust, J., de Baère, T., Auperin, A., Deschamps, F., Hechelhammer, L., Abdel-Rehim, M., Schlumberger, M. J., Leboulleux, S., & Baudin, É. (2010) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2010.05.020 · Cited by 61
Jouinot, A., & Bertherat, J. Y. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0027 · Cited by 61
Future directions in the diagnosis and medical treatment of adrenocortical carcinoma
Creemers, S. G., Hofland, L. J., Korpershoek, E., Franssen, G. J. H., van Kemenade, F. J., de Herder, W. W., & Feelders, R. A. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0452 · Cited by 61
Long noncoding RNA profiles of adrenocortical cancer can be used to predict recurrence
Glover, A. R., Zhao, J., Ip, J. C. Y., Lee, J. C., Robinson, B. G., Gill, A. J., Soon, P., & Sidhu, S. B. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0457 · Cited by 58
Duregon, E., Rapa, I., Votta, A., Giorcelli, J., Daffara, F., Terzolo, M., Scagliotti, G. V., Volante, M., & Papotti, M. G. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.04.005 · Cited by 63
Weissferdt, A., Phan, A. T., Suster, S. M., & Moran, C. A. (2013) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e31828a96cf · Cited by 58
Ad4BP in the human adrenal cortex and its disorders
Sasano, H., Shizawa, S., Suzuki, T., Takayama, K., Fukaya, T., Morohashi, K.-I., & Nagura, H. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.8.7629233 · Cited by 62
Sant, H. P. V., Bouvy, N. D., Geert Kazemier, M., Bonjer, H. J., Hop, W. C. J., Feelders, R. A., de Herder, W. W., & de Krijger, R. R. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02747.x · Cited by 56
Tissier, F., Aubert, S., Leteurtre, E., Ghuzlan, A. A., Patey, M., Decaussin‐Petrucci, M., Doucet, L., Gobet, F., Hoang, C., Mazerolles, C., et al. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31825a6308 · Cited by 55
Höfle, G., Gasser, R. W., Lhotta, K., Janetschek, G., Kreczy, A., & FINKENSTEDT, G. (1998) · Hormone Research in Paediatrics · doi:10.1159/000023282 · Cited by 56
Nakamura (2015) · doi:10.1016/j.ecl.2015.02.007 · Cited by 55
Shariq, O. A., & McKenzie, T. J. (2021) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223211033103 · Cited by 63
Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation cases
Duregon, E., Volante, M., Bollito, E., Goia, M., Buttigliero, C., Zaggia, B., Berruti, A., Scagliotti, G. V., & Papotti, M. G. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.08.012 · Cited by 55
Surgery is associated with improved survival for adrenocortical cancer, even in metastatic disease
Livhits, M. J., Li, N., Yeh, M. W., & Harari, A. (2014) · Surgery · doi:10.1016/j.surg.2014.08.047 · Cited by 55
Wang, C., Sun, Y., Wu, H., Zhao, D., & Chen, J. (2013) · Histopathology · doi:10.1111/his.12283 · Cited by 55
Transcription factor adrenal 4 binding protein as a marker of adrenocortical malignancy
Sasano, H., Shizawa, S., Suzuki, T., Takayama, K., Fukaya, T., Morohashi, K.-I., & Nagura, H. (1995) · Human Pathology · doi:10.1016/0046-8177(95)90280-5 · Cited by 55
Magro, G. G., Esposito, G., Cecchetto, G., Dall’Igna, P., Marcato, R., Gambini, C., Boldrini, R., Collini, P., Donofrio, V., Salfi, N. C. M., et al. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.04.016 · Cited by 54
Cyclin E correlates with malignancy and adverse prognosis in adrenocortical tumors
Tissier, F., Louvel, A., Grabar, S., Hagnéré, A.-M., Bertherat, J. Y., Vacher‐Lavenu, M., Dousset, B. E., Chapuis, Y., BERTAGNA, X. Y., & Gicquel, C. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500809 · Cited by 54
Song, S. Y., Park, S., Kim, S. R., et al. (2004) · Pathology International · doi:10.1111/j.1440-1827.2004.01669.x · Cited by 53
Dall’Igna, P., Virgone, C., Salvo, G. L. D., Bertorelle, R., Indolfi, P., Paoli, A. D., Buffa, P., Conte, M., Esposito, G., Inserra, A., et al. (2014) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2014.03.006 · Cited by 53
Das, S., Sengupta, M., Islam, N., Roy, P., Datta, C., Mishra, P. K., Banerjee, S., Chaudhuri, M. K., & Chatterjee, U. (2016) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2016.07.014 · Cited by 54
Is laparoscopic adrenalectomy feasible for adrenocortical carcinoma or metastasis?
Porpiglia, F., Fiori, C., Tarabuzzi, R., et al. (2004) · British Journal of Urology · doi:10.1111/j.1464-410x.2004.05098.x · Cited by 53
Proliferation in adrenocortical tumors: Correlation with clinical outcome and p53 status
McNicol, A. M., Struthers, A. J., Nolan, C. E., Hermans, J., & Haak, H. R. (1997) · Endocrine Pathology · doi:10.1007/bf02739705 · Cited by 51
Chatterjee, G., Dasgupta, S., Mukherjee, G., Sengupta, M., Roy, P., Arun, I., Datta, C., Mishra, P. K., Banerjee, S., & Chatterjee, U. (2015) · Pediatric Surgery International · doi:10.1007/s00383-015-3708-x · Cited by 52
Barzon, L., Pacenti, M., Masi, G., Stefani, A., Fincati, K., & Palù, G. (2005) · Oncology · doi:10.1159/000086983 · Cited by 52
Long-Term (15 Years) Outcome in an Infant with Metastatic Adrenocortical Carcinoma
León, D. D. D., Lange, B. J., Walterhouse, D. O., & Moshang, T. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011978 · Cited by 51
The 'omics' of adrenocortical tumours for personalized medicine
Assié, G., Jouinot, A., & Bertherat, J. Y. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.272 · Cited by 52
Adrenocortical carcinoma: presentation and outcome of a contemporary patient series
Kostiainen, I., Hakaste, L., Kejo, P., Parviainen, H., Laine, T., Löyttyniemi, E., Pennanen, M., Arola, J. T., Haglund, C. H., Heiskanen, I., et al. (2019) · Endocrine · doi:10.1007/s12020-019-01918-9 · Cited by 53
Laparoscopic surgery is safe for large adrenal lesions
Soon, P. S. H., Yeh, M. W., Delbridge, L., Bambach, C. P., Sywak, M. S., Robinson, B. G., & Sidhu, S. B. (2007) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2007.03.007 · Cited by 51
Côté, R. J., Cordon‐Cardo, C., Reuter, V. E., et al. (1990) · PubMed · Cited by 51
Profile and outcome of pure androgen-secreting adrenal tumors in women: experience of 21 cases
Moreno, S., Montoya, G., Armstrong, J., Leteurtre, E., Aubert, S., Vantyghem, M.-C., Dewailly, D., Wemeau, J.-L., & Proye, C. (2004) · Surgery · doi:10.1016/j.surg.2004.06.046 · Cited by 51
Kerkhofs, T. M. A., Ettaieb, M. H. T., Verhoeven, R. H. A., Kaspers, G. J. L., Tissing, W. J. E., Loeffen, J. L. C., van den Heuvel‐Eibrink, M. M., de Krijger, R. R., & Haak, H. R. (2014) · Oncology Reports · doi:10.3892/or.2014.3506 · Cited by 52
Sedláček, Z., Kodet, R., Kriz, V., Seemanová, E., Vodvarka, P., Wilgenbus, P., Mareš, J., Poustka, A. J., & Goetz, P. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.172 · Cited by 49
Pathobiology and genetics of adrenocortical carcinoma
Pittaway, J. F. H., & Guasti, L. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0122 · Cited by 49
Wanis, K. N., & Kanthan, R. (2015) · World Journal of Surgical Oncology · doi:10.1186/s12957-015-0527-4 · Cited by 49
Barreau, O., de Reyniès, A., Wilmot-Roussel, H., Guillaud-Bataille, M., Auzan, C., René-Corail, F., Tissier, F., Dousset, B. E., BERTAGNA, X. Y., Bertherat, J. Y., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1588 · Cited by 49
Urinary steroid profile in adrenocortical tumors
Kikuchi, E., Yanaihara, H., Nakashima, J., Homma, K., Ohigashi, T., Asakura, H., Tachibana, M., Shibata, H., Saruta, T., & Murai, M. (2000) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(00)80043-8 · Cited by 49
Wakatsuki, S., Sasano, H., Matsui, T., Nagashima, K., Toyota, T., & Horii, A. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90052-1 · Cited by 49
Clinical significance of the large adrenal mass
Khafagi, F. A., Gross, M. D., Shapiro, B., et al. (1991) · British journal of surgery · doi:10.1002/bjs.1800780720 · Cited by 49
Wnt/β-catenin activation cooperates with loss of p53 to cause adrenocortical carcinoma in mice
Borges, K. S., Pignatti, E., Leng, S., Kariyawasam, D., Ruiz‐Babot, G., Ramalho, F. S., Taketo, M. M., Carlone, D. L., & Breault, D. T. (2020) · Oncogene · doi:10.1038/s41388-020-1358-5 · Cited by 52
Pathologic features and expression of insulin-like growth factor-2 in adrenocortical neoplasms
Erickson, L. A., Jin, L., Sebo, T. J., Lohse, C., Pankratz, V. S., Kendrick, M. L., van Heerden, J. A., Thompson, G. B., Grant, C. S., & Lloyd, R. V. (2001) · Endocrine Pathology · doi:10.1385/ep:12:4:429 · Cited by 48
Soon, P. S. H., Libé, R., Benn, D. E., Gill, A. J., Shaw, J., Sywak, M. S., Groussin, L., BERTAGNA, X. Y., Gicquel, C., Bertherat, J. Y., et al. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e318153ff55 · Cited by 48
Adrenal Localization in the Adrenocorticotropic Hormone-Independent Cushing Syndrome
Fig, L. M., Gross, M. D., Shapiro, B., et al. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-7-547 · Cited by 48
Senescence-induced immune remodeling facilitates metastatic adrenal cancer in a sex-dimorphic manner
Warde, K. M., Smith, L., Liu, L., Stubben, C., Lohman, B. K., Willett, P. W., Ammer, J. L., Castaneda-Hernandez, G., Imodoye, S. O., Zhang, C., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00420-2 · Cited by 52
Adrenal cortical tumors, pheochromocytomas and paragangliomas
Lloyd, R. V. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.126 · Cited by 47
Erickson, L. A., Rivera, M., & Zhang, J. (2014) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000019 · Cited by 47
Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy
Koperski, Ł., Kotlarek, M., Świerniak, M., Kolanowska, M., Kubiak, A., Górnicka, B., Jażdżewski, K., & Wójcicka, A. (2017) · Oncotarget · doi:10.18632/oncotarget.16788 · Cited by 47
A Diagnostic Approach to Adrenocortical Tumors
Hodgson, A., Pakbaz, S., & Mete, Ö. (2019) · Surgical pathology clinics · doi:10.1016/j.path.2019.08.005 · Cited by 48
Boulle, N., Baudin, É., Gicquel, C., Logié, A., Bertherat, J. Y., Penfornis, A., BERTAGNA, X. Y., Luton, J., Schlumberger, M. J., & Bouc, Y. L. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440029 · Cited by 47
Fukuda, T., Takahashi, K., Suzuki, T., Saruta, M., Watanabe, M., Nakata, T., & Sasano, H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0090 · Cited by 47
Feinmesser, M., Benbassat, C. A., Meiri, E., Benjamin, H., Lebanony, D., Lebenthal, Y., de Vries, L., Drozd, T., & Spector, Y. (2014) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000117 · Cited by 46
Phan, L. M., Fuentes‐Mattei, E., Wu, W., Velázquez-Torres, G., Sircar, K., Wood, C. G., Hai, T., Jiménez, C., Cote, G. J., Ozsari, L., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3707 · Cited by 46
Diffuse malignant mesothelioma of pleura: Diagnosis and survival in 92 cases
Adams, V. I., Unni, K. K., Muhm, J. R., Jett, J. R., Ilstrup, D. M., & Bernatz, P. E. (1986) · Cancer · doi:10.1002/1097-0142(19861001)58:7 · Cited by 159
Müssig, K., Wehrmann, M., Horger, M., Maser-Gluth, C., Häring, H.-U., & Overkamp, D. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345531 · Cited by 43
Ono, Y., Yamazaki, Y., Omata, K., Else, T., Tomlins, S. A., Rhayem, Y., Williams, T. A., Reincke, M., Carling, T., Monticone, S., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz235 · Cited by 46
Lu, L., Suzuki, T., Yoshikawa, Y., Murakami, O., Miki, Y., Moriya, T., Bassett, M. H., Rainey, W. E., Hayashi, Y., & Sasano, H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0069 · Cited by 45
Adrenocortical oncocytoma: Case report with immunocytochemical and ultrastructural study
Bégin, L. R. (1992) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01606884 · Cited by 45
Histologic Criteria for Adrenocortical Proliferative Lesions
Blanes, A., & Díaz‐Cano, S. J. (2007) · American Journal of Clinical Pathology · doi:10.1309/mcguq3r4a4wwn3lb · Cited by 44
Oncocytic adrenocortical carcinoma
Ohtake, H., Kawamura, H., Matsuzaki, M., Yokoyama, E., Kitajima, M., Onizuka, S., & Yamakawa, M. (2009) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2009.06.006 · Cited by 44
Actual 10‐year survivors following resection of adrenocortical carcinoma
Tran, T. B., Postlewait, L. M., Maithel, S. K., Prescott, J. D., Wang, T. S., Glenn, J. A., Phay, J. E., Keplinger, K. M., Fields, R. C., Jin, L. X., et al. (2016) · Journal of Surgical Oncology · doi:10.1002/jso.24439 · Cited by 44
Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors
Kiiveri, S., Liu, J., Arola, J. T., Heikkilä, P., Kuulasmaa, T., Lehtonen, E., Voutilainen, R., & Heikinheimo, M. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.01.012 · Cited by 44
P53 and Ki67 in Adrenocortical Tumors
Arola, J. T., Salmenkivi, K., Liu, J., Kahri, A., & Heikkilä, P. (2000) · Endocrine Research · doi:10.3109/07435800009048609 · Cited by 44
Metadata
- Authors
- Weiss, L. M.
- Corresponding author
- Weiss, Lawrence M.
- ORCID
- Weiss, Lawrence M.
- Venue
- The American Journal of Surgical Pathology
- Published
- 1984-03
- Volume
- 8
- Issue
- 3
- Pages
- 163-170
- ISSN
- 0147-5185 (ISSN-L)
- OpenAlex
- W2039836243
- Cited by
- 920
- References
- 0
- Citations by year
- 2026: 21 · 2025: 19 · 2024: 24 · 2023: 23 · 2022: 31 · 2021: 38 · 2020: 36 · 2019: 24 · 2018: 32 · 2017: 28 · 2016: 39 · 2015: 44 · 2014: 50 · 2013: 29 · 2012: 26
- FWCI
- 6.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Surgical Pathology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Keywords
- adrenocortical tumors, adrenal metastasis, tumor recurrence, histologic grading, mitotic activity, atypical mitoses, venous invasion, capsular invasion, clear cells, tumor differentiation, adrenocortical carcinoma
- MeSH terms
- Adenoma, Adrenal Cortex Neoplasms, Adult, Aged, Carcinoma, Female, Humans, Male, Middle Aged, Mitosis, Necrosis, Neoplasm Recurrence, Local, Prognosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review